Acinetobacter Baumannii Infections in Critical Care Settings

Acinetobacter baumannii is an opportunistic Gram-negative pathogen that has emerged as a leading cause of healthcare-associated infections in intensive care units worldwide. Its remarkable capacity to survive on dry surfaces and form biofilms on medical devices facilitates transmission among critically ill patients. Multidrug resistance is commonplace, with many strains exhibiting resistance to carbapenems and other key antibiotic classes, and some isolates progressing to extensively drug-resistant profiles. Clinical manifestations include ventilator-associated pneumonia, bloodstream infections and wound infections, all of which are associated with prolonged hospital stays and high mortality rates. Management is complicated by limited therapeutic options, necessitating a combination of antimicrobial stewardship, rigorous infection control and ongoing surveillance. Recent advances in molecular epidemiology and predictive modelling are informing targeted interventions, but challenges remain in early diagnosis, prevention of cross-transmission and development of novel antimicrobials.

Research from Nature Portfolio

Recent work employing an invertebrate infection model revealed that early mortality in A. baumannii bloodstream infections is driven more by host severity of illness than by inherent virulence differences among clinical isolates. Larval mortality assays demonstrated no independent effect of isolate virulence on seven-day survival, whereas established clinical risk scores remained the predominant predictors of outcome. This finding underscores the importance of prompt recognition of patient risk factors and optimisation of supportive care over a sole focus on strain-specific virulence traits.

Acinetobacter Baumannii Infections in Critical Care Settings publication trend

The graph below shows the total number of articles in acinetobacter baumannii infections in critical care settings across all publications each year (not limited to Nature Index journals).

Technical terms

Multidrug-resistant (MDR): Bacterial isolates resistant to at least three classes of antimicrobial agents.

Extensively drug-resistant (XDR): Strains susceptible to only one or two categories of available antibiotics.

Bacteremia: Presence of bacteria in the bloodstream, often leading to systemic inflammatory response and sepsis.

Colonization: Detection of a microorganism at a body site without signs of tissue invasion or clinical infection.

Nomogram: A graphical predictive tool that integrates multiple variables to estimate individual risk probabilities.

Quorum sensing: Bacterial cell-to-cell communication via chemical signals that regulates gene expression in a population density-dependent manner.

References

1. Limited impact of bacterial virulence on early mortality risk factors in Acinetobacter baumannii bacteremia observed in a Galleria mellonella model. Scientific Reports (2024).
2. Using time-series chest radiographs and laboratory data by machine learning for identifying pulmonary infection and colonization of Acinetobacter baumannii. Respiratory Research (2024).
3. The Comparative Characterization of a Hypervirulent Acinetobacter baumannii Bacteremia Clinical Isolate Reveals a Novel Mechanism of Pathogenesis. International Journal of Molecular Sciences (2024).
4. Evaluating the efficiency of a nomogram based on the data of neurosurgical intensive care unit patients to predict pulmonary infection of multidrug-resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology (2023).